United Kingdom - English - myHealthbox

actavis group ptc ehf - linezolid - film-coated tablets - 600mg - other antibacterials - nosocomial pneumonia community acquired pneumonia linezolid is indicated for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria. in determining whether linezolid is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among gram positive bacteria should be taken into consideration. (see section 5.1 for the appropriate organisms). linezolid is not active against infections caused by gram negative pathogens. specific therapy against gram negative organisms must be initiated concomitantly if a gram negative pathogen is documented or suspected.

Ireland - English - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - linezolid - film-coated tablet - 600 milligram(s) - other antibacterials; linezolid

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - linezolid - film-coated tablet - 600 milligram(s) - other antibacterials; linezolid

Ireland - English - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid

Australia - English - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - linezolid -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; microcrystalline cellulose; magnesium stearate; purified talc; poloxamer; colloidal anhydrous silica; sodium starch glycollate type a; propylene glycol; brilliant blue fcf; ethanol; purified water; shellac; strong ammonia solution; titanium dioxide; hypromellose; macrogol 400 - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. ,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected

Canada - English - Health Canada

sandoz canada incorporated - linezolid - solution - 2mg - linezolid 2mg - oxazolidinones

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - linezolid - oral tablet - 600mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - linezolid - oral tablet - 600mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - linezolid - oral tablet - 600mg